Inpatient Discharge Summary  Emily Rose, MRN# 411678234, is a 54 y.o. female, admitted to the Cardiology service for management of acute myocardial infarction and newly diagnosed atrial fibrillation. Admission Date: 9/8/2023 Discharge Date: 9/15/2023 Attending Provider: Dr. Henry Fielding.  **Treatment Team**: SA3 FLOOR CALLS - PAGER 25501 Hospital Problems Noted - Resolved  POA Active Problems: - Acute myocardial infarction 9/8/2023 - Present Yes - Atrial fibrillation 9/8/2023 - Present Yes Resolved Problems: - Hypertension 9/8/2023 - 9/15/2023 Yes  **Follow-Up Recommendations**:  Attention to Primary Care Attending: (diagnostic studies and exam findings) - General follow-up. To Do's for Referring / Subspecialty Provider(s): - Cardiology: Follow-up appointment on 9/22/2023.  - Internal Medicine: Check labs in one week.  **Lab, Diagnostic Testing, and Referral Follow-Up**  Orders given to patient:  Discharge Medication List: - Aspirin 81 mg tablet once daily - Metoprolol 50 mg tablet twice daily - Warfarin 5 mg daily, with instructions for INR monitoring - Atorvastatin 40 mg at bedtime  Other Instructions: - No strenuous activities for 4 weeks - Monitor blood pressure and heart rate daily  Scheduled Appointments: Future Appointments Date Time Provider Department Center  9/22/2023 10:00 AM Dr. Alice Monroe, MD CARDIOLOGY St John's Heart Institute  **Pertinent Clinical Presentation on Admission/Reason for Hospitalization**: 54-year-old female presented to the ER with chest pain and shortness of breath on 9/8/2023. EKG confirmed ST-segment elevation in anterior leads and troponin was elevated at arrival. Immediate coronary angiography performed showed occlusion of the proximal left anterior descending artery, successfully treated with stent placement.  **Brief Hospital Course**:  Ms. Rose was admitted to the cardiology unit post-procedure. She developed atrial fibrillation on the second day of admission, which was managed with rate control and anticoagulation. Hypertension was well controlled with adjustments in medication. The patient responded well to the treatment, with resolution of chest pain and stabilization of cardiac enzymes.   **Discharge Condition**: Stable Disposition: Home  **Last Recorded Vital Signs**: BP 120/80 mmHg, Pulse 72, Temp 98.6 Â°F, Resp 16, O2 Sat 98% on room air.  **Pertinent Discharge Physical Exam Findings**:  General: Well appearing, no distress Cardiovascular: Regular rate and rhythm, no murmurs Respiratory: Clear to auscultation Extremities: No edema   **Significant Test or Procedure Results**:  Coronary Angiography: Successful stent placement in the proximal left anterior descending artery. Echocardiogram: EF 45%, no significant valvular abnormalities.  **Medications at Discharge**:  Continued Aspirin, Metoprolol, Warfarin, and Atorvastatin as started in hospital.  Endorsed by:  Signed: Dr. Henry Fielding, MD 9/15/2023, 4:00 PM - Supervising Physician: Ready for consultation upon request. - I agree with the note and plan which I have reviewed and edited where appropriate. 